Advice to Patients
- Importance of patients informing clinician of existing or contemplated concomitant therapy, including prescription and OTC drugs.
- Importance of women informing clinician if they are or plan to become pregnant or plan to breast-feed.
- Importance of informing patients with phenylketonuria that oral effervescent tablets for solution contain aspartame.
- When used for self-medication, importance of reading the product labeling and carefully reviewing the warning information provided by the manufacturer.
- Importance of following dosage instructions, unless otherwise directed by a clinician, when ranitidine is administered for self-medication.
- Importance of promptly informing clinician of persistent abdominal pain or difficulty swallowing.
- Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Ranitidine Hydrochloride
| Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
| Oral | Capsules, liquid-filled | 150 mg (of ranitidine)* |
Ranitidine Hydrochloride Capsules | Sandoz, Teva |
| | 300 mg (of ranitidine)* |
Ranitidine Hydrochloride Capsules | Sandoz, Teva |
| Solution | 75 mg (of ranitidine) per 5 mL |
Zantac® Syrup (with alcohol 7.5% and parabens) | GlaxoSmithKline |
| Tablets, film-coated | 75 mg (of ranitidine)* |
Ranitidine Hydrochloride Tablets | Ranbaxy, Sandoz, Teva, Watson |
| | |
Zantac® 75 | Pfizer |
| | 150 mg (of ranitidine)* |
Zantac® | GlaxoSmithKline |
| | |
Zantac® Maximum Strength 150 | GlaxoSmithKline |
| | 300 mg (of ranitidine)* |
Zantac® | GlaxoSmithKline |
| Tablets, for solution | 25 mg (of ranitidine) |
Zantac® EFFERdose® (with aspartame and povidone) | GlaxoSmithKline |
| | 150 mg (of ranitidine) |
Zantac® EFFERdose® (with aspartame and povidone) | GlaxoSmithKline |
| Parenteral | Injection | 25 mg (of ranitidine) per mL* |
Ranitidine Injection (with phenol 0.5%) | Bedford |
| | |
Zantac® (with phenol 0.5%) | GlaxoSmithKline |
| Injection, for preparation of IV admixtures | 25 mg (of ranitidine) per mL (1 g) pharmacy bulk package |
Zantac® (with phenol 0.5%) | GlaxoSmithKline |
| * available generically |
Ranitidine Hydrochloride in Sodium Chloride
| Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
| Parenteral | Injection | 1 mg (of ranitidine) per mL (50 mg) in 0.45% Sodium Chloride |
Zantac® Premixed (in flexible plastic container; preservative-free) | GlaxoSmithKline |
Comparative Pricing
This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
| Ranitidine HCl 15MG/ML Syrup | ACTAVIS MID ATLANTIC | 30/$29.99 or 90/$62.97 |
| Ranitidine HCl 150MG Capsules | PAR | 60/$35.99 or 90/$44.97 |
| Ranitidine HCl 150MG Tablets | RANBAXY PHARMACEUTICALS | 90/$14.99 or 180/$23.99 |
| Ranitidine HCl 300MG Capsules | SANDOZ | 30/$30.99 or 90/$79.99 |
| Ranitidine HCl 300MG Tablets | SANDOZ | 90/$18 or 180/$22 |
| Zantac 15MG/ML Syrup | GLAXO SMITH KLINE | 300/$224.88 or 900/$656.64 |
| Zantac 150MG Tablets | GLAXO SMITH KLINE | 60/$200.24 or 180/$588.1 |
| Zantac 300MG Tablets | GLAXO SMITH KLINE | 30/$169.99 or 90/$489.96 |
| Zantac 75 75MG Tablets | PFIZER CONS HEALTH | 60/$20.99 or 180/$55.96 |
| Zantac 75 75MG Tablets | PFIZER CONS HEALTH | 10/$7.99 or 30/$13.38 |
| Zantac 75 75MG Tablets | PFIZER CONS HEALTH | 20/$7.99 or 60/$21.12 |
| Zantac 75 75MG Tablets | PFIZER CONS HEALTH | 30/$17.99 or 60/$26.98 |
| Zantac 75 75MG Tablets | PFIZER CONS HEALTH | 4/$8.99 or 12/$9.99 |
| Zantac EFFERdose 25MG Effervescent Tablets | GLAXO SMITH KLINE | 60/$179.98 or 180/$509.87 |
AHFS Drug Information. © Copyright, 1959-2008, Selected Revisions July 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
Remember, keep this and all other medicines out of the reach of children,
never share your medicines with others, and use this medication only for the indication prescribed.